• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Transgenomic to Incorporate Horizon Discovery's Genomic Reference Standards into Multiplexed ICE COLD-PCR™ Kits

    Transgenomic to Incorporate Horizon Discovery's Genomic Reference Standards into Multiplexed ICE COLD-PCR™ Kits

  2. Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 2015 AACR Annual Meeting

    Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 2015 AACR Annual Meeting

  3. Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO

    Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO

  4. OncoCyte Announces Initial Data From Ongoing Clinical Study of Collagen Type X as a Marker and Potential Diagnostic for Breast Cancer and Other Types of Human Cancers

    OncoCyte Announces Initial Data From Ongoing Clinical Study of Collagen Type X as a Marker and Potential Diagnostic for Breast Cancer and Other Types of Human Cancers

  5. Oncolytics Biotech® Inc. Presents at UK Immuno-oncology Meeting

    Oncolytics Biotech® Inc. Presents at UK Immuno-oncology Meeting

  6. Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Gastric Cancer

    Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Gastric Cancer

  7. Technavio Publishes Global Melanoma Therapeutics Market Analysis and Forecast 2015-2019

    Technavio Publishes Global Melanoma Therapeutics Market Analysis and Forecast 2015-2019

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.